Evidence map›Paper›PMID 38283125›Full record

ArticleF1000Research2022

Case Report: A rare case of symptomatic bradycardia secondary to aripiprazole in a patient with bipolar disorder type I.

Mailing Flores Chang, Nehemias Guevara, Marlon Argueta, Yomary Jimenez, Adler Vitaly, Salim Baghdadi

Open access · goldAbstract readCase Reports
In one paragraph

Article in F1000Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mailing Flores ChangDepartment of Medicine, Internal Medicine, St. Barnabas Health System, The Bronx, New York, 10487, USA.
Nehemias GuevaraDepartment of Medicine, Internal Medicine, St. Barnabas Health System, The Bronx, New York, 10487, USA.ORCID 0000-0003-3808-0803
Marlon ArguetaDepartment of Medicine, Internal Medicine, St. Barnabas Health System, The Bronx, New York, 10487, USA.
Yomary JimenezDepartment of Medicine, Internal Medicine, St. Barnabas Health System, The Bronx, New York, 10487, USA.
Adler VitalyDepartment of Medicine, Internal Medicine, St. Barnabas Health System, The Bronx, New York, 10487, USA.
Salim BaghdadiDepartment of Medicine, Internal Medicine, Division of Cardiology, St. Barnabas Hospital Health System, The Bronx, New York, 10457, USA.
St. Barnabas Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that typical antipsychotic drugs have been implicated as a cause of ventricular arrhythmias and cardiac arrest; studies have shown that conventional antipsychotics increase the risk of hospitalization for ventricular arrhythmias or cardiac arrest nearly 2-fold. However, atypical antipsychotics are not associated with an increased risk of hospitalization for ventricular arrhythmias or cardiac arrest. The use of atypical antipsychotics increased since they were first discovered and now are the mainstay of treatment, but with their broad use, heart effects have been documented, such as prolonged QT interval. Clozapine has been linked to severe cardiac problems, and risperidone has been linked to an increased risk of ventricular arrhythmias and cardiac arrest. We present a case of a patient with bipolar disorder who presented with symptomatic bradycardia secondary to aripiprazole.

Indexed as

Antipsychotic AgentsBipolar DisorderHeart ArrestAripiprazoleArrhythmias, CardiacBradycardiaHumansAntipsychotic AgentsAripiprazoleAripiprazoleatypical antipsychoticBipolar disorder.Bradycardia

Identifiers

PMID38283125
PMCPMC10818102
OpenAlexW4307884990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.